ATE125551T1 - Amidderivate vom antibiotikum a 40926. - Google Patents

Amidderivate vom antibiotikum a 40926.

Info

Publication number: ATE125551T1
Authority: AT; Austria
Prior art keywords: antibiotic; amide derivatives; alkylaminocarbonyl; substituent; staplylococci
Prior art date: 1991-07-29

Application number

AT92915890T

Other languages

English (en)

Inventor

Adriano Malabarba

Romeo Ciabatti

Gianbattista Panzone

Alessandra Maria Marazzi

Original Assignee

Lepetit Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-07-29

Filing date

1992-07-14

Publication date

1995-08-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26128958&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE125551(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1992-07-14 Application filed by Lepetit Spa filed Critical Lepetit Spa

1995-08-15 Application granted granted Critical

1995-08-15 Publication of ATE125551T1 publication Critical patent/ATE125551T1/de

Links

-1 AMIDE DERIVATIVES OF ANTIBIOTIC A 40926 Chemical class 0.000 title 1
125000004457 alkyl amino carbonyl group Chemical group 0.000 abstract 2
BEVDFPMXVNOQBI-AXNWEOKVSA-N (19R,22R,34S,37R,40R,52S)-64-[(2S,3R,4R,5S,6S)-3-amino-6-carboxy-4,5-dihydroxyoxan-2-yl]oxy-5,32-dichloro-2,26,31,49-tetrahydroxy-22-(methylamino)-21,35,38,54,56,59-hexaoxo-47-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-7,13,28-trioxa-20,36,39,53,55,58-hexazaundecacyclo[38.14.2.23,6.214,17.219,34.18,12.123,27.129,33.141,45.010,37.046,51]hexahexaconta-3,5,8,10,12(64),14(63),15,17(62),23(61),24,26,29(60),30,32,41,43,45(57),46(51),47,49,65-henicosaene-52-carboxylic acid Chemical class CN[C@@H]1c2ccc(O)c(Oc3cc(O)c(Cl)c(c3)[C@@H]3NC(=O)[C@@H](Cc4ccc(Oc5cc6cc(Oc7ccc(cc7Cl)C(O)C7NC(=O)[C@H](NC(=O)[C@@H]6NC3=O)c3cccc(c3)-c3c(O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]6O)cc(O)cc3[C@H](NC7=O)C(O)=O)c5O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3N)C(O)=O)cc4)NC1=O)c2 BEVDFPMXVNOQBI-AXNWEOKVSA-N 0.000 abstract 1
DQJCDTNMLBYVAY-ZXXIYAEKSA-N (2S,5R,10R,13R)-16-{[(2R,3S,4R,5R)-3-{[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-(ethylamino)-6-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy}-5-(4-aminobutyl)-10-carbamoyl-2,13-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazaheptadecan-1-oic acid Chemical compound NCCCC[C@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)CC[C@H](C(N)=O)NC(=O)[C@@H](C)NC(=O)C(C)O[C@@H]1[C@@H](NCC)C(O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@@H](CO)O1 DQJCDTNMLBYVAY-ZXXIYAEKSA-N 0.000 abstract 1
102000002068 Glycopeptides Human genes 0.000 abstract 1
108010015899 Glycopeptides Proteins 0.000 abstract 1
125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 abstract 1
238000000338 in vitro Methods 0.000 abstract 1
229920000768 polyamine Chemical group 0.000 abstract 1
125000001424 substituent group Chemical group 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
- C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
- C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Genetics & Genomics (AREA)
Oncology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Communicable Diseases (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Cephalosporin Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

AT92915890T 1991-07-29 1992-07-14 Amidderivate vom antibiotikum a 40926. ATE125551T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP91112685		1991-07-29
EP92109906		1992-06-12

Publications (1)

Publication Number	Publication Date
ATE125551T1 true ATE125551T1 (de)	1995-08-15

Family

ID=26128958

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT92915890T ATE125551T1 (de)	1991-07-29	1992-07-14	Amidderivate vom antibiotikum a 40926.

Country Status (24)

Country	Link
EP (2)	EP0525499A1 (de)
JP (1)	JP3418762B2 (de)
KR (1)	KR100242682B1 (de)
AT (1)	ATE125551T1 (de)
AU (1)	AU666862B2 (de)
BG (1)	BG61124B2 (de)
CA (1)	CA2109601C (de)
CZ (1)	CZ285703B6 (de)
DE (1)	DE69203724T2 (de)
DK (1)	DK0596929T3 (de)
ES (1)	ES2075709T3 (de)
FI (1)	FI112662B (de)
GR (1)	GR3017897T3 (de)
HU (2)	HU223946B1 (de)
IE (1)	IE68420B1 (de)
IL (1)	IL102623A (de)
MX (1)	MX9204394A (de)
NO (1)	NO314150B1 (de)
NZ (1)	NZ243735A (de)
PL (1)	PL171813B1 (de)
RU (1)	RU2125058C1 (de)
TW (1)	TW218021B (de)
UA (1)	UA41283C2 (de)
WO (1)	WO1993003060A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5606036A (en) *	1991-03-27	1997-02-25	Gruppo Lepetit Spa	Antibiotic A 40926 ester derivatives
US5840684A (en) *	1994-01-28	1998-11-24	Eli Lilly And Company	Glycopeptide antibiotic derivatives
NZ270387A (en) *	1994-01-28	1996-11-26	Lilly Co Eli	Glycopeptide antibiotic, its production and compositions thereof
WO1997002288A1 (en) *	1995-07-05	1997-01-23	Gruppo Lepetit S.P.A.	Purification of dalbaheptide antibiotics by isoelectric focusing
WO1997040067A1 (en) *	1996-04-23	1997-10-30	Biosearch Italia S.P.A.	Improved chemical process for preparing amide derivatives of antibiotic a 40926
US6004959A (en) *	1996-05-30	1999-12-21	Hoechst Marion Roussel, Inc.	Alkyloxyamino substituted fluorenones and their use as protein kinase-C inhibitors
SG87877A1 (en) *	1998-12-23	2002-04-16	Advanced Medicine Inc	Glycopeptide derivatives and pharmaceutical compositions containing the same
DK1140993T3 (da) *	1998-12-23	2003-10-06	Theravance Inc	Glycopeptidderivater og farmaceutiske præparater indeholdende dem
TWI275594B (en)	2001-08-24	2007-03-11	Theravance Inc	Process for preparing vancomycin phosphonate derivatives
TWI312785B (en)	2001-08-24	2009-08-01	Theravance Inc	Process for preparing vancomycin derivatives
KR100478533B1 (ko) *	2002-07-30	2005-03-28	한국수력원자력 주식회사	레이저를 이용한 탈륨 동위원소 분리방법
US20050090433A1 (en)	2002-11-18	2005-04-28	Vicuron Pharmaceuticals, Inc	Dalbavancin compositions for treatment of bacterial infections
US20060074014A1 (en)	2002-11-18	2006-04-06	Vicuron Pharmaceuticals Inc.	Dalbavancin compositions for treatment of bacterial infections
US7119061B2 (en) *	2002-11-18	2006-10-10	Vicuron Pharmaceuticals, Inc.	Dalbavancin compositions for treatment of bacterial infections
EP1641480A1 (de)	2003-05-27	2006-04-05	Theravance, Inc.	Verwendung eines antimykotischen polyen-makrolids in kombination mit einem antibakteriellen glycopeptid-mittel
ES2298821T3 (es)	2003-07-22	2008-05-16	Theravance, Inc.	Utilizacion de un agente antifungico de equinocandina en combinacion con un agente antibacteriano glicopeptidico.
MX2007006319A (es)	2004-11-29	2007-07-25	Univ Nagoya Nat Univ Corp	Derivados de monomeros de glicopeptico antibioticos.
TW200808818A (en)	2006-05-26	2008-02-16	Shionogi & Co	Glycopeptide antibiotic derivatives
CA2710417A1 (en)	2007-12-26	2009-07-02	Shionogi & Co., Ltd.	Glycosylated glycopeptide antibiotic derivatives
US20240083950A1 (en) *	2021-01-11	2024-03-14	Xellia Pharmaceuticals Aps	Synthesis process

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8608809D0 (en) *	1986-04-11	1986-05-14	Lepetit Spa	Antibiotic
GB8726859D0 (en) *	1987-11-17	1987-12-23	Lepetit Spa	22-dechlorotei-coplanins
EP0376041B1 (de) *	1988-12-27	1996-02-28	GRUPPO LEPETIT S.p.A.	C63-Amidderivate von 34-de(acetylglucosaminyl)-34-deoxy-teicoplaninen
GB2231846B (en) *	1989-05-25	1993-02-24	Hadlum Brothers Ltd	A hand held carrier
HUT63860A (en) *	1990-12-05	1993-10-28	Lepetit Spa	Process for producing 39-decarboxy-38-(hydroxymethyl) derivatives of teikoplanin antibiotics
DE69215665T2 (de) *	1991-03-27	1997-06-12	Gruppo Lepetit S.P.A., Lainate	Esterderivate von antibiotikum-a 40926

1992
- 1992-07-14 AT AT92915890T patent/ATE125551T1/de not_active IP Right Cessation
- 1992-07-14 ES ES92915890T patent/ES2075709T3/es not_active Expired - Lifetime
- 1992-07-14 PL PL92302285A patent/PL171813B1/pl not_active IP Right Cessation
- 1992-07-14 DK DK92915890.5T patent/DK0596929T3/da active
- 1992-07-14 HU HU9400256A patent/HU223946B1/hu not_active IP Right Cessation
- 1992-07-14 WO PCT/EP1992/001594 patent/WO1993003060A1/en not_active Ceased
- 1992-07-14 AU AU23262/92A patent/AU666862B2/en not_active Ceased
- 1992-07-14 UA UA94005300A patent/UA41283C2/uk unknown
- 1992-07-14 JP JP50320293A patent/JP3418762B2/ja not_active Expired - Fee Related
- 1992-07-14 EP EP92111932A patent/EP0525499A1/de active Pending
- 1992-07-14 KR KR1019940700273A patent/KR100242682B1/ko not_active Expired - Fee Related
- 1992-07-14 CZ CZ94192A patent/CZ285703B6/cs not_active IP Right Cessation
- 1992-07-14 RU RU94013457A patent/RU2125058C1/ru not_active IP Right Cessation
- 1992-07-14 CA CA002109601A patent/CA2109601C/en not_active Expired - Fee Related
- 1992-07-14 DE DE69203724T patent/DE69203724T2/de not_active Expired - Fee Related
- 1992-07-14 EP EP92915890A patent/EP0596929B1/de not_active Expired - Lifetime
- 1992-07-17 TW TW081105668A patent/TW218021B/zh not_active IP Right Cessation
- 1992-07-23 IL IL10262392A patent/IL102623A/en not_active IP Right Cessation
- 1992-07-27 NZ NZ243735A patent/NZ243735A/xx unknown
- 1992-07-27 MX MX9204394A patent/MX9204394A/es not_active IP Right Cessation
- 1992-07-28 IE IE922451A patent/IE68420B1/en not_active IP Right Cessation
1993
- 1993-12-20 NO NO19934722A patent/NO314150B1/no not_active IP Right Cessation
1994
- 1994-01-26 FI FI940394A patent/FI112662B/fi active
- 1994-02-25 BG BG098582A patent/BG61124B2/bg unknown
1995
- 1995-06-19 HU HU95P/P00252P patent/HU211347A9/hu unknown
- 1995-10-26 GR GR950402996T patent/GR3017897T3/el unknown

Also Published As

Publication number	Publication date
AU666862B2 (en)	1996-02-29
IE922451A1 (en)	1993-02-10
HU9400256D0 (en)	1994-05-30
IL102623A0 (en)	1993-01-14
BG61124B2 (bg)	1996-11-29
GR3017897T3 (en)	1996-01-31
NO314150B1 (no)	2003-02-03
FI940394L (fi)	1994-01-26
PL171813B1 (pl)	1997-06-30
EP0525499A1 (de)	1993-02-03
HUT66080A (en)	1994-09-28
TW218021B (de)	1993-12-21
FI940394A0 (fi)	1994-01-26
ES2075709T3 (es)	1995-10-01
AU2326292A (en)	1993-03-02
JP3418762B2 (ja)	2003-06-23
UA41283C2 (uk)	2001-09-17
IL102623A (en)	1996-10-16
NO934722D0 (no)	1993-12-20
IE68420B1 (en)	1996-06-12
FI112662B (fi)	2003-12-31
CZ285703B6 (cs)	1999-10-13
NO934722L (no)	1994-02-14
HU211347A9 (en)	1995-11-28
EP0596929B1 (de)	1995-07-26
NZ243735A (en)	1995-01-27
CA2109601C (en)	2002-07-02
JPH06509347A (ja)	1994-10-20
DE69203724D1 (de)	1995-08-31
WO1993003060A1 (en)	1993-02-18
KR100242682B1 (ko)	2000-02-01
EP0596929A1 (de)	1994-05-18
RU2125058C1 (ru)	1999-01-20
CA2109601A1 (en)	1993-02-18
HU223946B1 (hu)	2005-03-29
MX9204394A (es)	1993-01-29
CZ19294A3 (en)	1994-11-16
DK0596929T3 (da)	1995-09-11
DE69203724T2 (de)	1996-01-18

Legal Events

Date	Code	Title
1996-01-15	UEP	Publication of translation of european patent specification
2003-12-15	EEIH	Change in the person of patent owner
2011-04-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE125551T1 (de)	1995-08-15	Amidderivate vom antibiotikum a 40926.
DK0934950T3 (da)	2002-07-29	Tetrapeptidderivat
ATE282630T1 (de)	2004-12-15	Dolastatin-derivate
NO2006018I1 (no)	2006-12-27	Entekavir:(2-amino-1,9-dihydro-9Ä(1S,3R,4S)-4hydroksy-3-(hydroksymetyl)-2-metylencyklopentylÜ-6H-purin-6-on og hydrater derav, saerlig monohydrat
ATE338744T1 (de)	2006-09-15	Hydrazonderivate
RU94013457A (ru)	1995-09-10	Амидные производные антибиотика а 40926
PT825186E (pt)	2002-08-30	Derivados de 2-aminobenzazepina e sua utilizacao para o tratamento da imunossupressao
BR9608873A (pt)	1999-07-06	Inibidores de selectina de moléculas pequenas di e trivalentes
DE3851179D1 (de)	1994-09-29	Oxetanocin.
ATE99298T1 (de)	1994-01-15	1,4,8-triazacyclotridecan-derivate mit prolylendopeptidase-hemmender wirkung.
BG102647A (en)	1999-04-30	Acyclic nucleoside derivatives
ATE90685T1 (de)	1993-07-15	Disaccharidderivate.
FI963568A0 (fi)	1996-09-10	Peptidijohdannaisia
ES2097435T3 (es)	1997-04-01	Derivados de 2,16-bispiperidinilandrostano monocuaternarios.
ATE197953T1 (de)	2000-12-15	Pyrrolo(4,3,2-de)chinolin-derivat
ES2149180T3 (es)	2000-11-01	Derivado de pirazolotiazolopirimidina.
ATE119911T1 (de)	1995-04-15	Angolamycin-derivate.